| Dr Christina Irene Fredenberg, MD | |
|
9250 No. 3rd St., Suite 4000, Phoenix, AZ 85020 | |
| (602) 633-3800 | |
| (602) 861-3500 |
| Full Name | Dr Christina Irene Fredenberg |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 9250 No. 3rd St., Phoenix, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982703757 | NPI | - | NPPES |
| 740309 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 29993 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christina Irene Fredenberg, MD 9250 No. 3rd St, Suite 4000, Phoenix, AZ 85020 Ph: (602) 633-3800 | Dr Christina Irene Fredenberg, MD 9250 No. 3rd St., Suite 4000, Phoenix, AZ 85020 Ph: (602) 633-3800 |
News Archive
New analysis from Alzheimer's Research UK, the UK's leading dementia research charity, has revealed that the number of scientists working on the condition has almost doubled over six years.
Emerging Healthcare Solutions, Inc. is negotiating a potential option agreement with biotech firm Regenetech, Inc.
Dr Alex Mitchell, of the Department of Cancer Studies and Molecular Medicine at the University of Leicester, led the study which has been published in the journal General Hospital Psychiatry. Dr Mitchell said preventive screening refers to population based medical tests such as mammography, colonoscopy, blood pressure testing or cholesterol levels to detect conditions such as cancer, diabetes or heart conditions. These screening programmes are typically administered widely in order to help with early detection or prevention and have been credited with improving outcomes of several key medical conditions.
If hospitals can perform more transradial, same-day percutaneous coronary intervention, or PCIs, not only will patients benefit because it is associated with have less complications, but collectively, hospitals across the U.S. could save $300 million each year, according to research published today in JACC: Cardiovascular Interventions.
Tris Pharma, an emerging specialty pharmaceutical company, announced the US grant of its core technology patent for its OralXR+ platform. This is the first patent grant of a substantial estate filed by Tris Pharma and covers a multitude of actives having modified release formulations comprising drug-ion exchange resin complexes.
› Verified 6 days ago
Dr. Natasha Elizabeth Lewis, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
Dr. Nasma Kamil Majeed, MD Pathology Medicare: Medicare Enrolled Practice Location: 1111 E Mcdowell Rd, Phoenix, AZ 85006 Phone: 602-685-5211 Fax: 623-322-4639 | |
David J Glembocki, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 11130 N Tatum Blvd, Suite 100, Phoenix, AZ 85028 Phone: 602-494-1817 Fax: 602-494-7103 | |
Suzan Kavusi, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 650 E Indian School Rd, Phoenix, AZ 85012 Phone: 602-277-5551 | |
Dr. Maria P Alzona, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 424 S 56th St Ste 120, Phoenix, AZ 85034 Phone: 602-685-5211 Fax: 602-685-5325 | |
Anna Marie Felty-duckworth, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 650 E Indian School Rd, Cs/113, Phoenix, AZ 85012 Phone: 602-277-5551 Fax: 602-222-2669 | |
Renuka Pathi, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 22216 N 36th St, Phoenix, AZ 85050 Phone: 602-606-7375 |